Stimulating erythropoiesis before hip fracture repair for reducing blood transfusion: should we change the hemoglobin cutoff level for defining anemia in females?

Transfusion

Volumn 56, Issue 9, 2016, Pages 2160-2163

  Muñoz, Manuel ^a   Gómez Ramírez, Susana ^b   Auerbach, Michael ^c,d  

^a UNIVERSITY OF MÁLAGA   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c Auerbach Hematology and Oncology   (United States)

^d GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRIC CARBOXYMALTOSE; FERRITIN; HEMOGLOBIN; IRON; IRON SACCHARATE; PHOSPHATE; PLACEBO; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

ADVERSE OUTCOME; ALLOGENEIC BLOOD TRANSFUSION; ANEMIA; BLOOD TRANSFUSION; BLOOD VOLUME; COMORBIDITY; DRUG EFFICACY; EDITORIAL; ERYTHROCYTE CONCENTRATE; ERYTHROPOIESIS; FEMALE; HEMATOCRIT; HIP FRACTURE; HUMAN; HYPOTENSION; IRON DEFICIENCY; ORTHOPEDIC SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE TREATMENT; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SURVIVAL RATE;

EID: 84987619343     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13750     Document Type: Editorial

References (30)

1. Gullberg B, Johnell O, Kanis JA. World-wide projections for hip fracture. Osteoporos Int 1997;7:407-13.
2. Gruson KI, Aharonoff GB, Egol KA, et al. The relationship between admission hemoglobin level and outcome after hip fracture. J Orthop Trauma 2002;16:39-44.
3. Madsen CM, Jørgensen HL, Norgaard A, et al. Preoperative factors associated with red blood cell transfusion in hip fracture patients. Arch Orthop Trauma Surg 2014;134:375-82.
4. Shokoohi A, Stanworth S, Mistry D, et al. The risks of red cell transfusion for hip fracture surgery in the elderly. Vox Sang 2012;103:223-30.
5. WHA 63.12 (resolution). Availability, safety and quality of blood products [Internet]. Geneva: World Health Organization; 2010 May 21. [cited June 2016]. Available from: http://apps.who.int/gb/ebwha/pdf_files/WHA63/A63_R12-en.Pdf.
6. Shander A, Van Aken H, Colomina MJ, et al. Patient blood management in Europe. Br J Anaesth 2012;109:55-68.
7. Muñoz M, Gómez-Ramírez S, Kozek-Langeneker S, et al. ‘Fit to fly’: overcoming barriers to preoperative haemoglobin optimization in surgical patients. Br J Anaesth 2015;115:15-24.
8. Brunskill SJ, Millette SL, Shokoohi A, et al. Red blood cell transfusion for people undergoing hip fracture surgery (review). Cochrane Database Syst Rev 2015;(4):CD009699.
9. Zufferey PJ, Miquet M, Quenet S, et al. Tranexamic acid in hip fracture surgery: a randomized controlled trial. Br J Anaesth 2010;104:23-30.
10. Does tranexamic acid reduce the need for blood transfusions in patients undergoing hip fracture surgery? [Internet]. NCT01714336. Bethesda: U.S. National Library of Medicine; 2012 [cited 2016 Jun 6]. Available from: https://clinicaltrials.gov/ct2/show/results/NCT01714336?term=NCT+01714336&rank=1.
11. Muñoz M, Iglesias D, Garcia-Erce JA, et al. Utility and cost of low-vacuum reinfusion drains in patients undergoing surgery for subcapital hip fracture repair. A before and after cohort study. Vox Sang 2014;106:83-91.
12. Kateros K, Sakellariou VI, Sofianos IP, et al. Epoetin alfa reduces blood transfusion requirements in patients with intertrochanteric fracture. J Crit Care 2010;25:348-53.
13. Serrano-Trenas JA, Font-Ugalde P, Muñoz-Cabello L, et al. Role of perioperative intravenous iron therapy in elderly hip fracture patients. A single center randomized controlled trial. Transfusion 2011;51:97-104.
14. Muñoz M, Gómez-Ramírez S, Cuenca J, et al. Very-short-term perioperative intravenous iron administration and postoperative outcome in major orthopedic surgery: a pooled analysis of observational data from 2547 patients. Transfusion 2014;54:289-99.
15. Bernabeu-Wittel M, Romero M, Ollero-Baturone M, et al. Ferric carboxymaltose with or without erythropoietin in anemic patients with hip fracture: a randomized clinical trial. Transfusion. 2016 May 14. doi: 10.1111/trf.13624
16. Cuenca J, García-Erce JA, Muñoz M, et al. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. Transfusion 2004;44:1447-52.
17. Cuenca J, García-Erce JA, Martínez AA, et al. Role of parenteral iron in the management of anaemia in the elderly patient undergoing displaced subcapital hip fracture repair. Preliminary data. Arch Orthop Trauma Surg 2005;125:342-7.
18. Weber EW, Slappendel R, Hémon Y, et al. Effects of epoetin alfa on blood transfusions and postoperative recovery in orthopaedic surgery: the European Epoetin Alfa Surgery Trial (EEST). Eur J Anaesthesiol 2005;22:249-57.
19. Gombotz H, Rehak PH, Shander A, et al. Blood use in elective surgery: the Austrian benchmark study. Transfusion 2007;47:1468-80.
20. Rosencher N, Kerkkamp HE, Macheras G, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion 2003;43:459-69.
21. García-Erce JA, Laso-Morales MJ, Gómez-Ramírez S, et al. Analysis of the prevalence and causes of low preoperative haemoglobin levels in a large multicentre cohort of patients undergoing major non-cardiac surgery [abstract]. Transfus Med 2016;26:48.
22. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity [Internet]. WHO/NMH/NHD/MNM/11.1. Geneva: World Health Organization; 2011 [cited 2016 Jun 6]. Available from: http://www.who.int/vmnis/indicators/haemoglobin.pdf.
23. Weltert L, Rondinelli B, Bello R, et al. A single dose of erythropoietin reduces perioperative transfusions in cardiac surgery: results of a prospective single-blind randomized controlled trial. Transfusion 2015;55:1644-54.
24. Yoo YC, Shim JK, Kim JC, et al. Effect of single recombinant human erythropoietin injection on transfusion requirements in preoperatively anemic patients undergoing valvular heart surgery. Anesthesiology 2011;115:929-37.
25. Na HS, Shin SY, Hwang JY, et al. Effects of intravenous iron combined with low-dose recombinant human erythropoietin on transfusion requirements in iron-deficient patients undergoing bilateral total knee replacement arthroplasty. Transfusion 2011;51:118-24.
26. Carson JL, Terrin ML, Noveck H, et al. Liberal or restrictive transfusion in high-risk patients after hip surgery. N Engl J Med 2011;365:2453-62.
27. Hébert PC, Wells G, Blajchman MA, et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999;340:409-17.
28. Carson JL, Grossman BJ, Kleinman S, et al. Red blood cell transfusion: a clinical practice guideline from the AABB. Ann Intern Med 2012;157:49-58.
29. Hardy S, Vandemergel X. Intravenous iron administration and hypophos-phatemia in clinical practice. Int J Rheumatol 2015;2015:468675.
30. Muñoz M, Martín-Montañez E. Ferric carboxymaltose for the treatment of iron-deficiency anemia [corrected]. Expert Opin Pharmacother 2012;13:907-21.